Envafolimab Combined with Recombinant Human Endostatin and Chemotherapy for NSCLC

被引：0
|
作者：
Miao, C. [1 ]
Yuan, S. [1 ]
机构：
[1] Univ Sci & Technol China, Prov Hosp, Hefei, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
Envafolimab; Rh-endostatin; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4.11E.07
引用
收藏
页码：S397 / S397
页数：1
相关论文
共 50 条
  • [41] Effect of recombinant human endostatin onradiotherapy for esophagus cancer
    Liu, Gao-Feng
    Chang, Hui
    Li, Bao-Tian
    Zhang, Yong
    Li, Dan-Dan
    Liu, Yan
    Yang, Yang
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2016, 9 (01) : 84 - 88
  • [42] A RETROSPECTIVE STUDY OF RECOMBINANT HUMAN ENDOSTATIN COMBINED WITH CARBOPLATIN AND VINCRISTINE FOR PEDIATRIC LOW-GRADE GLIOMAS
    Zhang, Jun-Ping
    NEURO-ONCOLOGY, 2019, 21 : 187 - 187
  • [43] Effect of recombinant human endostatin onradiotherapy for esophagus cancer
    Gao-Feng Liu
    Hui Chang
    Bao-Tian Li
    Yong Zhang
    Dan-Dan Li
    Yan Liu
    Yang Yang
    Asian Pacific Journal of Tropical Medicine, 2016, (01) : 84 - 88
  • [44] Antiangiogenic effects of recombinant human endostatin in lung cancers
    He, Lang
    Zhao, Chaofen
    Li, Yunxiang
    Du, Guocheng
    Liu, Kang
    Cui, Dandan
    Tang, Lina
    Wu, Xun
    Wen, Shimin
    Chen, Hong
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 79 - 86
  • [45] Pharmacokinetics of PEGylated recombinant human endostatin in rhesus monkeys
    Guo, Lifang
    Li, Zuogang
    Xu, Benshan
    Yu, Min
    Fu, Yan
    Liu, Lihong
    Wang, Junzhi
    Luo, Yongzhang
    LIFE SCIENCES, 2019, 238
  • [46] Biophysical and biological characterization of PEGylated recombinant human endostatin
    Guo, Lifang
    Xu, Benshan
    Zhou, Daifu
    Chang, Guodong
    Fu, Yan
    Liu, Lihong
    Luo, Yongzhang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (10) : 920 - 927
  • [47] Real-world effectiveness and safety of PD-1 inhibitors combined with recombinant human endostatin and chemotherapy in refractory, recurrent/metastatic nasopharyngeal carcinoma.
    Huang, Shuang
    Cao, Caineng
    Qiang, Mengyun
    Hua, Yonghong
    Jin, Qifeng
    Jin, Ting
    Chen, Xiaozhong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [48] A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer
    Jing Zhao
    Xinxiao Chen
    Aimu Zhang
    Feng Xu
    Meilong Hu
    Congying Xie
    Shengliu Xue
    Medical Oncology, 2014, 31
  • [49] A pilot study of combination intraperitoneal recombinant human endostatin and chemotherapy for refractory malignant ascites secondary to ovarian cancer
    Zhao, Jing
    Chen, Xinxiao
    Zhang, Aimu
    Xu, Feng
    Hu, Meilong
    Xie, Congying
    Xue, Shengliu
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [50] Inhibitory effect of radiotherapy combined with weekly recombinant human endostatin on the human pulmonary adenocarcinoma A549 xenografts in nude mice
    Jiang, Xiao-dong
    Dai, Peng
    Wu, Jin
    Song, Da-an
    Yu, Jin-ming
    LUNG CANCER, 2011, 72 (02) : 165 - 171
12345